Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer

Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer

US Patent 11524960 · Granted Dec 13, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of plasma kallikrein and uses thereof2025
Therapeutically active compounds and their methods of use2025
Therapeutically active compounds and their methods of use2025
Therapeutically active compounds and their methods of use2025
Lentinula edodes-derived saltiness enhancing peptide, method for preparing the s2025
Plasma kallikrein inhibitors and uses thereof2025
Method of preparing a fusion reactor divertor component2024
Pyruvate kinase activators for use in treating blood disorders2024
Solid target system for radionuclide preparation2024
Detection kit for Salmonella typhi, preparation method and application thereof2024
Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024
Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024